Delivery Order SPE2DB24D2205-SPE2DB25FEHZG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,131.88 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 198 mg, a testosterone replacement medication. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,182.21 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg, a testosterone replacement therapy medication. This non-competitive delivery order was issued on August 13, 2025, with completion targeted for August 14, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, utilizing firm fixed price pricing under a delivery order contract type. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,988.39 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Jatenzo 237 mg capsules (120 count) valued at $1,640.34. This firm fixed-price delivery order, which is scheduled for completion by August 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,532.10 by the Defense Logistics Agency on June 6, 2025, with an ultimate completion date of June 9, 2025. The contract covers the supply of Jatenzo 198 mg capsules (120-count package), a testosterone replacement therapy medication. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. The award is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Jatenzo 198 mg capsules (120-count units) valued at $1,131.88 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of August 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $3,347.66 for Jatenzo 198 mg capsules (120-count units) with a completion date of September 4, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Jatenzo 237 mg capsules (120 count) with a ceiling value of $2,263.74. This is a firm fixed-price contract with an ultimate completion date of September 18, 2025. The award was competitively made with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under a...
- The Defense Logistics Agency has awarded a delivery order valued at $1,697.81 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg, a testosterone replacement therapy medication. This is a firm fixed-price, non-set-aside contract awarded on September 25, 2025, with completion expected by September 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,131.87 delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg, a testosterone replacement therapy medication. This competitively awarded, firm fixed-price contract was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHZGDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 24, 2025, for 120 capsules of Jatenzo 237 mg, a testosterone replacement therapy medication, with a ceiling value of $1,724.77. The contract is a firm fixed price delivery order with an ultimate completion date of September 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded through the federal procurement process. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's role in this pharmaceutical prime vendor arrangement demonstrates its critical position in the military healthcare supply chain, providing both brand-name and generic drugs across multiple therapeutic domains to support military personnel and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/24/25 |